BIIB Stock Ownership Activity
BIOGEN INC 13F holders
No value investing guru has made any change to the BIOGEN INC (BIIB) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying BIIB now?
According to the latest SEC filing(s) BIOGEN INC (BIIB) has not been purchased by any super investor.
To see more about who is investing in BIOGEN INC (BIIB), please go to the BIIB ownership page.
2017 Q2
(3 results)
Current price: $217.81
19.74%
AVG reported price*: $271.36
2017 Q1
(3 results)
Current price: $217.81
20.33%
AVG reported price*: $273.39
2016 Q4
(3 results)
Current price: $217.81
23.19%
AVG reported price*: $283.57
2016 Q3
(3 results)
Current price: $217.81
33.16%
AVG reported price*: $325.89
2016 Q2
(3 results)
Current price: $217.81
14.02%
AVG reported price*: $253.33
2016 Q1
(3 results)
Current price: $217.81
16.33%
AVG reported price*: $260.32
2015 Q4
(2 results)
Current price: $217.81
28.94%
AVG reported price*: $306.51
2015 Q3
(1 result)
Current price: $217.81
46.08%
Reported price*: $403.94
2015 Q2
(1 result)
Current price: $217.81
46.08%
Reported price*: $403.94
2014 Q2
(1 result)
Current price: $217.81
28.79%
Reported price*: $305.87
2014 Q1
(1 result)
Current price: $217.81
28.79%
Reported price*: $305.87
2013 Q4
(1 result)
Current price: $217.81
9.53%
Reported price*: $240.76
2013 Q3
(1 result)
Current price: $217.81
9.53%
Reported price*: $240.76
2013 Q2
(1 result)
Current price: $217.81
1.21%
Reported price*: $215.20
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.